Taiwan Bio Completes TregCel Transfer, Phase 2 Trial on Horizon
Taiwan Bio Therapeutics, Inc. and TRACT Therapeutics, Inc. have achieved a key milestone with the successful transfer of TRACT’s TregCel platform technology to Taiwan Bio’s…
Taiwan Bio Therapeutics, Inc. and TRACT Therapeutics, Inc. have achieved a key milestone with the successful transfer of TRACT’s TregCel platform technology to Taiwan Bio’s…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.